Clinical Trial Search

Primary: Antimicrobial Activity of the Investigational Products Compared to Control. — 3.85; 3.91; 3.87; 3.84 log10 CFU/cm^2

Primary: Percentage of Appropriate Antimicrobial Prescriptions Recommended — 90 percentage of prescriptions appropriate

Primary: Relative GAS Survival — 100; 75; 90 percentage overall bacterial abundance

Primary: Total Bacterial Contamination of Healthcare Worker Uniform With Antimicrobial Properties Compared to Standard Healthcare Worker Uniform After an 8-hour Workday. — 41…

Primary: Change in the Release of Skin Flora From the Hands From Baseline to 5 Minutes After Disinfection by Surgical Scrubbing (Time Frame- "Baseline and 5 Minutes"). — 3.96…

Primary: Change in Mean Number of Skin Bacterial Counts From Baseline to 72 Hours — -1.91; -1.87 log 10 CFU/cm sq — p=<0.001

Primary: Evaluate the Residual Effect of Chlorhexidine 2% / Isopropyl Alcohol 70% Administered Topically — 24; 48; 24 (CFU/cm2) — p=<0.05

Primary: Bacterial Colony Forming Units Present on Hand Prints After Time Spent in Common Areas — 2.17; 1.81 log(10) transformed CFU

Primary: Change in the Abundance of Staphylococcus Aureus in the Nose After Decolonization — -4174 fg/uL

Primary: Change in Clinical Attachment Level (CAL) — 3.69; 3.62; 2.4; 3 mm

Primary: Number of Participants With Postoperative Healthcare Acquired Infections — 108; 116 Participants

Primary: MRSA and VRE Clinical Cultures — 0.87; 0.79 Hazard Ratio (Intervention vs Baseline) — p=0.17

Primary: Total Bacteria Count Change From Baseline and After 24 Hours. — -62519; 57448 CFU/mL — p=0.6250

Primary: Susceptability Changes in Streptococcus Pneumoniae Distal to the Site of Instillation — 0; 0; 0; 0 Percent of resistant isolates

Primary: Number of Patients With a Positive Propionibacteria Swabs on Day of Surgery After At-Home Washes With Benzoyl Peroxide or Chlorhexidine Gluconate — 25; 24; 14; 11…

Primary: Change in Bacterial Microflora in the Inguinal Area — -3.86; -4.34; -3.65; -3.80 log10 CFU

Primary: Rate of UTI While Colonized With E. Coli 83972. — 8.5 UTIs per 1000 patient-days

Primary: Bacterial Count of Skin Cultures for the 10% Povidone-iodine Period — 231 Colony-forming units per cm squared — p=<0.05

Primary: Total Number of Detectable Plaque Bacteria Sampled 3 Days Post Implant Surgery — 7.63; 7.43 log(10) colony forming equivalents (CFE) — p=0.2965

Primary: Subjects Who Developed Antibiotic Resistance Organisms — 0; 0; 1; 0 Participants

Primary: Number of Participants With a Superficial Incisional Surgical Site Infection (SSI) — 13; 7 Participants

Primary: Number of Participants With Surgical Site Infection — 7; 4 participants

Primary: Degree of Microbial Disruption: Number of Patients With Recovery of Bacterial Species Richness at 185 Days Post-antibiotics — 3; 3; 2; 3 Participants

Primary: Number of Catheter-Related Blood Stream Infections (CRBSI) at 6 Months — 1.98; 2.09; 1.73; 1.02 Infections per 1000 days with catheter

Primary: Rate of Infection — 113; 113 Participants

Primary: Periodontal Probing Depth — 2.5; 3.2; 3.4 millimeter

Primary: Number of Participants With Composite of the Cure Rate as Measured by Clinical Response and Outcome at the Early Efficacy Visit Combined With Withdrawal Rate — 48; 28…

Primary: Number of Subjects With Positive Bacterial Growth Culture Per Treatment Arms — 10; 12; 10; 10 participants

Primary: Percentage of Patient-visits Prescribed an Antimicrobial at Their ED Visit — 21.2; 20.9; 19.1; 21.6 percentage of visits prescribed an abx — p=0.35

Primary: Number of Participants With a Superficial Incisional Surgical Site Infection (SSI) — 20; 27; 6; 9 Participants